Ratings by Freedom Capital (Il)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/30/2026 Intensity Therapeutics, Inc. INTS Upgrade Buy
(Hold)
6.03
(4.02)
-33.33% Details